Awarded $49 Million in Trial Against Life’s Applera Unit
By Susan Decker - Nov 2, 2012 9:46 AM ET.
Enzo Biochem Inc. was awarded $48.6 million after a federal jury said Life Technologies Corp. (LIFE)’s Applera unit infringed a patent over a way to detect genetic sequences and diagnose human diseases such as cancer.
The federal jury in New Haven, Connecticut, rejected Applera’s claims that the patent was invalid. Enzo said it will ask for interest that could add tens of millions of dollars to the final damage award.